Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04314336
Other study ID # 1520192020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2019
Est. completion date June 1, 2020

Study information

Verified date December 2020
Source Bjelovar General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators have performed cost-minimisation analysis and compared the expenses based on the plan for public procurement (without clinical pharmacist involvement) for drugs with the results of public procurement based on the revised plan for public procurement by the clinical pharmacist. The plan for public procurements was based on the 1 year quantity for each medicine used by the hospital in the previous year, based on the latest deliverable prices at the time of extracting the data to workbook for MS Excel program (ver. 2002, Microsoft, Redmond, WA, USA). The investigators have performed cost-minimisation analysis and compared the expenses for all received requests for medicines to the drug and therapeutics committee (DTC) for a decision in the 1 year period, before and after involvement of clinical pharmacist in the committee work. The expenses were based on approval decisions in the 1 year period for approval time period. The denial decisions were also calculated and reported. The denial period calculated in rationalisation of expenses were based on 1 year treatment period.


Recruitment information / eligibility

Status Completed
Enrollment 10000
Est. completion date June 1, 2020
Est. primary completion date May 1, 2020
Accepts healthy volunteers No
Gender All
Age group 1 Year to 100 Years
Eligibility Inclusion Criteria: - All patients in the hospital (inhospital patients) Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Public procurement
Cost minimisation study through public procurement
Drug and Therapeutics Committee
Cost minimisation analysis of results of the drug and therapeutics committee before and after clinical pharmacist involvement

Locations

Country Name City State
Croatia General Hospital Bjelovar Bjelovar

Sponsors (1)

Lead Sponsor Collaborator
Bjelovar General Hospital

Country where clinical trial is conducted

Croatia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reducing prices of medicines Reduce prices of medicines in percentage, since different countries and hospitals have various budgets and medicine prices 1 year
Secondary Rationalization of expenses Rationalization of expenses through rquests for medicines sent to Drug and Therapeutics Committee 1 year